Author

Xiang Liu

University of MichiganORCID 0000-0002-8165-3294Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xiang Liu7 papers · Zhejiang University

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Developmental Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

Bo WeniD· 1 shared Chunpeng Yang· 1 shared Duxin SuniD· 1 shared Furong ChengiD· 1 shared Guizhi ZhuiD· 1 shared Guolan Xiao· 1 shared Hanning Wen· 1 shared Jinze LiuiD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Bo WenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BMP4 is sufficient to induce a caudal organizer

Yan-Yi Xing, Ying Huang, Tao Cheng, Tao Luo, Yang Dong, Zi-Xin Jin, Yi-Meng Tian, Xiang Liu, Jun Ma, Junfeng Ji, Peng‐Fei Xu

This study shows that BMP4 alone can induce a caudal organizer in zebrafish embryos and human pluripotent stem cells, replicating developmental processes seen in natural development.

bioRxiv · Nov 7, 2024 · PreprintDevelopmental Biology

Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma

Qiyan Wang, Ting Su, Furong Cheng, Shurong Zhou, Xiang Liu, Mi Wang, You Xu, Ri Tang, Shimiao Liao, Jordan M. Dailey, Guolan Xiao, Chunpeng Yang, Hanning Wen, Weijia Zheng, Bo Wen, , Guizhi Zhu

This paper introduces PROTAVs, a new vaccine strategy that enhances T cell responses and combination immunotherapy for melanoma by improving antigen processing and cross-presentation.

bioRxiv · Oct 1, 2024 · PreprintBioengineering